Shuo Chen, Lin Zhang, Kai Wang, Jizhen Huo, Siqi Zhang, Xipeng Zhang
{"title":"H2.0类同源异型盒在癌症发生发展中的潜在双重作用及其预后价值。","authors":"Shuo Chen, Lin Zhang, Kai Wang, Jizhen Huo, Siqi Zhang, Xipeng Zhang","doi":"10.1155/2023/5521544","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong><i>H2.0-like homeobox</i> (<i>HLX</i>) is highly expressed in several hematopoietic malignancies. However, the role of <i>HLX</i> in the carcinogenesis and progression of colorectal cancer (CRC) patients has rarely been reported.</p><p><strong>Methods: </strong>In this study, the data were collected from The Cancer Genome Atlas and Gene Expression Omnibus databases. The diagnostic value of <i>HLX</i> was analyzed by the R package \"pROC.\" The overall survival was estimated using the \"survival\" and \"survminer\" packages. A nomogram was established to predict 1-, 3-, and 5-year overall survival of CRC patients. The CIBERSORT software was employed to calculate the relative proportions of 22 immune cells.</p><p><strong>Results: </strong><i>HLX</i> expression was downregulated in CRC patients. Remarkably, <i>HLX</i> expression was increased with stage (stage I-stage III) of CRC, and the CRC patients with high <i>HLX</i> expression exhibited a poor prognosis. The promoter methylation level of <i>HLX</i> was prominently increased in CRC samples compared to paracancerous samples. We also found that the six miRNAs target <i>HLX</i> genes, leading to its downregulation, and <i>HLX</i> expression had a negative correlation with its downstream target gene <i>BRI3BP</i> in both CRC and normal samples. Finally, we found that the 12 immune infiltrating cells were observably different between high and low <i>HLX</i> expression groups. The <i>HLX</i> had a significant positive correlation with 8 immune checkpoints (PD-1 (PDCD1), CTLA4, PDL-1 (CD274), PDL-2 (PDCD1LG2), CD80, CD86, LAG3, and TIGIT) expressions.</p><p><strong>Conclusion: </strong><i>HLX</i> probably played a carcinostasis role in the early stages of CRC but exhibited a cancer-promoting effect in the advanced stages. Meanwhile, <i>HLX</i> could serve as a reliable prognostic indicator for CRC.</p>","PeriodicalId":48755,"journal":{"name":"Canadian Journal of Gastroenterology and Hepatology","volume":null,"pages":null},"PeriodicalIF":2.7000,"publicationDate":"2023-09-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10505080/pdf/","citationCount":"0","resultStr":"{\"title\":\"The Potential Dual Role of H2.0-like Homeobox in the Tumorgenesis and Development of Colorectal Cancer and Its Prognostic Value.\",\"authors\":\"Shuo Chen, Lin Zhang, Kai Wang, Jizhen Huo, Siqi Zhang, Xipeng Zhang\",\"doi\":\"10.1155/2023/5521544\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong><i>H2.0-like homeobox</i> (<i>HLX</i>) is highly expressed in several hematopoietic malignancies. However, the role of <i>HLX</i> in the carcinogenesis and progression of colorectal cancer (CRC) patients has rarely been reported.</p><p><strong>Methods: </strong>In this study, the data were collected from The Cancer Genome Atlas and Gene Expression Omnibus databases. The diagnostic value of <i>HLX</i> was analyzed by the R package \\\"pROC.\\\" The overall survival was estimated using the \\\"survival\\\" and \\\"survminer\\\" packages. A nomogram was established to predict 1-, 3-, and 5-year overall survival of CRC patients. The CIBERSORT software was employed to calculate the relative proportions of 22 immune cells.</p><p><strong>Results: </strong><i>HLX</i> expression was downregulated in CRC patients. Remarkably, <i>HLX</i> expression was increased with stage (stage I-stage III) of CRC, and the CRC patients with high <i>HLX</i> expression exhibited a poor prognosis. The promoter methylation level of <i>HLX</i> was prominently increased in CRC samples compared to paracancerous samples. We also found that the six miRNAs target <i>HLX</i> genes, leading to its downregulation, and <i>HLX</i> expression had a negative correlation with its downstream target gene <i>BRI3BP</i> in both CRC and normal samples. Finally, we found that the 12 immune infiltrating cells were observably different between high and low <i>HLX</i> expression groups. The <i>HLX</i> had a significant positive correlation with 8 immune checkpoints (PD-1 (PDCD1), CTLA4, PDL-1 (CD274), PDL-2 (PDCD1LG2), CD80, CD86, LAG3, and TIGIT) expressions.</p><p><strong>Conclusion: </strong><i>HLX</i> probably played a carcinostasis role in the early stages of CRC but exhibited a cancer-promoting effect in the advanced stages. Meanwhile, <i>HLX</i> could serve as a reliable prognostic indicator for CRC.</p>\",\"PeriodicalId\":48755,\"journal\":{\"name\":\"Canadian Journal of Gastroenterology and Hepatology\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":2.7000,\"publicationDate\":\"2023-09-09\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10505080/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Canadian Journal of Gastroenterology and Hepatology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1155/2023/5521544\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2023/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q2\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Canadian Journal of Gastroenterology and Hepatology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1155/2023/5521544","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"Medicine","Score":null,"Total":0}
The Potential Dual Role of H2.0-like Homeobox in the Tumorgenesis and Development of Colorectal Cancer and Its Prognostic Value.
Background: H2.0-like homeobox (HLX) is highly expressed in several hematopoietic malignancies. However, the role of HLX in the carcinogenesis and progression of colorectal cancer (CRC) patients has rarely been reported.
Methods: In this study, the data were collected from The Cancer Genome Atlas and Gene Expression Omnibus databases. The diagnostic value of HLX was analyzed by the R package "pROC." The overall survival was estimated using the "survival" and "survminer" packages. A nomogram was established to predict 1-, 3-, and 5-year overall survival of CRC patients. The CIBERSORT software was employed to calculate the relative proportions of 22 immune cells.
Results: HLX expression was downregulated in CRC patients. Remarkably, HLX expression was increased with stage (stage I-stage III) of CRC, and the CRC patients with high HLX expression exhibited a poor prognosis. The promoter methylation level of HLX was prominently increased in CRC samples compared to paracancerous samples. We also found that the six miRNAs target HLX genes, leading to its downregulation, and HLX expression had a negative correlation with its downstream target gene BRI3BP in both CRC and normal samples. Finally, we found that the 12 immune infiltrating cells were observably different between high and low HLX expression groups. The HLX had a significant positive correlation with 8 immune checkpoints (PD-1 (PDCD1), CTLA4, PDL-1 (CD274), PDL-2 (PDCD1LG2), CD80, CD86, LAG3, and TIGIT) expressions.
Conclusion: HLX probably played a carcinostasis role in the early stages of CRC but exhibited a cancer-promoting effect in the advanced stages. Meanwhile, HLX could serve as a reliable prognostic indicator for CRC.
期刊介绍:
Canadian Journal of Gastroenterology and Hepatology is a peer-reviewed, open access journal that publishes original research articles, review articles, and clinical studies in all areas of gastroenterology and liver disease - medicine and surgery.
The Canadian Journal of Gastroenterology and Hepatology is sponsored by the Canadian Association of Gastroenterology and the Canadian Association for the Study of the Liver.